Concepedia

Elona Biçaku

EB

21

Publications

1.6K

Citations

18

H-Index

2002

Active since

Affiliations

Moffitt Cancer Center(Current)

James A. Haley Veterans' Hospital

University of South Florida

University of California, San Francisco

Elona Biçaku is an author at Moffitt Cancer Center specializing in medicine, oncology, and cell biology.

Top concepts

Publications per year

2002–2015

21

Publications

21

Phase I Trial of Histone Deacetylase Inhibition by Valproic Acid Followed by the Topoisomerase II Inhibitor Epirubicin in Advanced Solid Tumors: A Clinical and Translational Study

Pamela N. Münster, Douglas C. Marchion, Elona Biçaku et al. · Journal of Clinical Oncology · 2007 · 218 citations · Full text

Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins

Douglas C. Marchion, Elona Biçaku, Adil Daud et al. · Cancer Research · 2005 · 216 citations · Full text

Sequence‐specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid

Douglas C. Marchion, Elona Biçaku, Adil Daud et al. · Journal of Cellular Biochemistry · 2004 · 185 citations

Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC

Pamela N. Münster, Douglas C. Marchion, Elona Biçaku et al. · Clinical Cancer Research · 2009 · 148 citations

Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy

Scott Thomas, Kenneth T. Thurn, Elona Biçaku et al. · Breast Cancer Research and Treatment · 2011 · 111 citations · Full text

, , +8

Rows per page

1–5 of 21